BIOSYNEX |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.21 EUR | +0.24% |
|
-20.75% | -49.70% |
| 04-30 | Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 04-29 | Biosynex: agreement for ProciseDx in North America | CF |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIOSYNEX | Diagnostic & Testing Substances | +0.24% | -20.75% | -49.70% | -42.54% | +51.62% | 48.27M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ALBIO Stock
- Charts Biosynex
- Comparison Chart
